Eris Lifesciences informs about outcome of board meeting

04 Aug 2020 Evaluate

Eris Lifesciences has informed that the Board of Directors of the Company at their meeting held today August 04, 2020, duly approved / took on record the Unaudited Standalone Financial Results and the Unaudited Consolidated Financial Results for the quarter ended June 30, 2020, Declaration of Interim Dividend of Rs 5.50 (at the rate of 550%) on each fully paid-up equity share of Re 1 for the Financial Year 2020-21, and Fixed 14th August, 2020 as the record date to determine the names of the equity shareholders, who shall be entitled to receive the payment towards interim dividend for the financial year 2020-21. The payment of the interim dividend would be made to the eligible shareholders on or before 3rd September, 2020. The meeting of the Board of Directors commenced at 11:00 am and concluded at 01:05 pm.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1552.75 -5.65 (-0.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×